ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $40,850,000 | 24.66% |
| Octagon Capital Advisors LP | 2,669,974 | $67,657,000 | 18.06% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,040,000 | 8.36% |
| BVF INC/IL | 3,960,948 | $100,370,000 | 4.85% |
| Finepoint Capital LP | 535,000 | $13,557,000 | 4.69% |
| PFM Health Sciences, LP | 3,346,458 | $84,799,000 | 3.24% |
| ACUTA CAPITAL PARTNERS, LLC | 167,500 | $4,244,000 | 2.36% |
| Boxer Capital, LLC | 1,432,200 | $36,292,000 | 2.30% |
| Parkman Healthcare Partners LLC | 171,214 | $4,339,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 311,782 | $7,901,000 | 1.59% |